Search results
Moderna's (MRNA) Omicron Based Jab gets Approval in Australia
Zacks via Yahoo Finance· 2 years agoModerna (MRNA) receives provisional approval in Australia for its Omicron-containing bivalent...
Moderna's (MRNA) Omicron-Specific Booster Jab Meets Study Goal
Zacks via Yahoo Finance· 2 years agoModerna, Inc. MRNA announced positive data from a phase II/III study, which evaluated its second...
CDC now also recommends Moderna's COVID vaccine for adolescents
CBS News via Yahoo News· 2 years agoThe Centers for Disease Control and Prevention's outside vaccine advisers voted unanimously Thursday...
Moderna pitches RSV shot, new vaccines after ‘difficult year of transition’
BioPharma Dive via Yahoo Finance· 3 months agoDive Brief: Moderna shares rose by as much as 10% Thursday morning after the COVID-19 vaccine...
FDA panel approves Moderna and Pfizer COVID vaccines for toddlers
NY Daily News via AOL· 2 years agoA vax for tots is on the way. A Food and Drug Administration advisory panel approved Moderna and...
Moderna starts application process for RSV vaccine for older adults
Reuters via Yahoo News· 11 months agoIt is aiming to be the third vaccine maker to get an approval in the country after GSK and Pfizer...
FDA greenlights updated mRNA Covid vaccines
Politico via Yahoo News· 8 months agoThe FDA on Monday cleared two updated mRNA Covid-19 shots from Pfizer-BioNTech and Moderna, paving the way for an early fall rollout. It will be the...
The Zacks Analyst Blog Highlights Moderna, RAPT Therapeutics, Iovance, Sarepta Therapeutics and...
Zacks via Yahoo Finance· 3 months agoFor Immediate Release Chicago, IL – February 23, 2024 – Zacks.com announces the list of stocks...
COVID vaccines for young children 'safest route' to protection from virus: CHOP doctors
Bucks County Courier Times via Yahoo News· 2 years agoBoth Pfizer and Moderna's COVID vaccines were shown in studies to produce "adequate" antibodies to...
Moderna (MRNA) Beats on Q2 Earnings & Sales, Raises '23 View
Zacks via Yahoo Finance· 10 months agoModerna (MRNA) beats expectations for earnings and sales. Management raises its product revenue...